ClinicalTrials.Veeva

Menu

Multi-level Molecular Profiling of Peak Performance in Endurance Sports (MSSA)

P

Paracelsus Medical University (PMU)

Status

Unknown

Conditions

Physical Fitness
Healthy
Exercise Test
Exercise

Treatments

Diagnostic Test: Performance testing

Study type

Interventional

Funder types

Other

Identifiers

NCT05359744
jestep032022

Details and patient eligibility

About

Physical activity triggers complex molecular responses, including changes in immune-, stress-, and metabolic pathways. For example, autophagy is essential for energy and cellular homeostasis through protein catabolism, and dysregulation results in compromised proteostasis, reduced exercise performance, and excessive secretion of signaling molecules and inflammatory proteins. However, previous research has been limited by the extend of molecules measured and biological processes covered. A better understanding of these processes through multi-omic analysis can improve knowledge of molecular changes in response to exercise. The main purpose of the investigators study is to analyze the effects of acute exercise in correlation to autophagy and other signaling cascades. Specifically, the investigators plan to perform multi-level molecular profiling in a cohort of healthy male elite cyclists and male and female recreational athletes, before, during, and after a bicycle ergometer test. The results will be compared to a control cohort without intervention.

Full description

This is a non-randomized controlled trial performed at the Paracelsus Medical University, Salzburg, Austria. The study will recruit 80 healthy men and women. Subjects who meet the inclusion criteria will be allocated to four arms (n = 20 in all groups): 1. elite cyclists, 2. male recreational athletes, 3. female recreational athletes, 4. male control group.

After overnight fasting and medical check-up, groups 1-3 will undergo a bicycle ergometer-based exercise protocol designed to span low (aerobic) to severe (anaerobic) domains of exercise. The protocol consists of a 15 min aerobic warm-up phase followed by a ramp-bicycle ergometer protocol.

During exercise, performance-relevant data will be continuously monitored. Venous blood specimens will be collected before exercise (baseline), at the end of the warm-up as well as 2 min, 10 min, and 30 min in recovery.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • All arms: ability to give written informed consent
  • Arms 1- 3: inconspicuous medical examination (medical history, resting ECG, echocardiography)
  • Elite athletes (arm1, cyclists): maximum oxygen uptake > 65 ml/kg/KG
  • Elite athletes (arm1, cyclists): participation in cycling competitions on a regular basis
  • Recreational athletes (arms 2 and 3): maximum oxygen uptake < 65 ml/kg/KG for male subjects and < 55 ml/kg/KG for female subjects

Exclusion criteria

  • All arms: unable to communicate adequately by language
  • All arms: regular use of prescription drugs other than thyroxine or antihistamines
  • All arms: alcohol consumption as equivalent doses averaging more than 40 g of pure alcohol per day
  • All arms: use of illicit drugs
  • All arms: known diseases of the cardiovascular system
  • All arms: arterial hypertension over 160/90 mmHg at rest
  • All arms: known pulmonary diseases, especially bronchial asthma
  • All arms: surgery less than 4-6 months ago.
  • All arms: abnormalities in the medical examination (medical history, resting ECG, echocardiography)
  • Arms 1-3: orthopaedic diseases that preclude maximum exercise on a bicycle ergometer
  • Elite athletes (arm1, cyclists): maximum oxygen uptake < 65 ml/kg/KG
  • Recreational athletes (arms 2 and 3): maximum oxygen uptake > 65 ml/kg/KG for male subjects and > 55 ml/kg/KG for female subjects
  • Arm 3: positive urine ß-HCG

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

80 participants in 4 patient groups

Elite cyclists, male
Experimental group
Description:
Bicycle ergometer-based exercise testing. 15 min aerobic warm-up phase (2 W/kg) followed by a standardized but individualized ramp-bicycle ergometer protocol to reach maximal exercise capacity after 8 - 12 minutes. The exclusively aerobic energy supply during warm-up will be assessed by constant respiratory quotient and constant arterial lactate concentration (\<0.5 mmol in the last 5 min). During exercise, respiratory gas exchange, heart rate, blood pressure, ECG and ratings of perceived exertion will be continuously monitored. Venous blood specimens will be collected before exercise (baseline), at the end of the warm-up as well as 2 min, 10 min, and 30 min in recovery.
Treatment:
Diagnostic Test: Performance testing
Recreational athletes, male
Experimental group
Description:
Bicycle ergometer-based exercise testing. 15 min aerobic warm-up phase (1 W/kg) followed by a standardized but individualized ramp-bicycle ergometer protocol to reach maximal exercise capacity after 8 - 12 minutes. The exclusively aerobic energy supply during warm-up will be assessed by constant respiratory quotient and constant arterial lactate concentration (\<0.5 mmol in the last 5 min). During exercise, respiratory gas exchange, heart rate, blood pressure, ECG and ratings of perceived exertion will be continuously monitored. Venous blood specimens will be collected before exercise (baseline), at the end of the warm-up as well as 2 min, 10 min, and 30 min in recovery.
Treatment:
Diagnostic Test: Performance testing
Recreational athletes, female
Experimental group
Description:
Bicycle ergometer-based exercise testing. 15 min aerobic warm-up phase (1 W/kg) followed by a standardized but individualized ramp-bicycle ergometer protocol to reach maximal exercise capacity after 8 - 12 minutes. The exclusively aerobic energy supply during warm-up will be assessed by constant respiratory quotient and constant arterial lactate concentration (\<0.5 mmol in the last 5 min). During exercise, respiratory gas exchange, heart rate, blood pressure, ECG and ratings of perceived exertion will be continuously monitored. Venous blood specimens will be collected before exercise (baseline), at the end of the warm-up as well as 2 min, 10 min, and 30 min in recovery.
Treatment:
Diagnostic Test: Performance testing
Control, male
No Intervention group
Description:
Venous blood specimens will be collected at the same time points in the absence of exercise.

Trial contacts and locations

1

Loading...

Central trial contact

Nils Gassen, PhD; Jens Stepan, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems